Stockscreener 앱 받기
37.85
4.44%
-1.76
시간 외 거래:
37.61
-0.24
-0.63%
전일 마감가:
$39.61
열려 있는:
$38.6
하루 거래량:
1.99M
Relative Volume:
0.85
시가총액:
$5.23B
수익:
$181.74M
순이익/손실:
$-143.97M
주가수익비율:
-27.23
EPS:
-1.39
순현금흐름:
$9.60M
1주 성능:
-4.30%
1개월 성능:
+4.79%
6개월 성능:
+162.48%
1년 성능:
+88.68%
1일 변동 폭
$37.77
$39.31
1주일 범위
$37.77
$43.69
52주 변동 폭
$9.57
$43.69
Arrowhead Pharmaceuticals Inc Stock (ARWR) Company Profile
명칭
Arrowhead Pharmaceuticals Inc
전화
626-696-4702
주소
177 E COLORADO BLVD, PASADENA, CA
ARWR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARWR
Arrowhead Pharmaceuticals Inc
|
37.85 | 5.48B | 181.74M | -143.97M | 9.60M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-05 | 개시 | Goldman | Neutral |
| 2023-12-04 | 개시 | BofA Securities | Buy |
| 2023-09-19 | 개시 | Citigroup | Neutral |
| 2023-07-21 | 개시 | TD Cowen | Outperform |
| 2023-05-12 | 다운그레이드 | SVB Securities | Outperform → Market Perform |
| 2023-04-26 | 개시 | SMBC Nikko | Outperform |
| 2023-04-12 | 업그레이드 | SVB Securities | Market Perform → Outperform |
| 2023-03-21 | 개시 | Bernstein | Mkt Perform |
| 2022-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-11 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-01-19 | 재개 | Goldman | Buy |
| 2021-08-06 | 재확인 | Chardan Capital Markets | Buy |
| 2021-06-04 | 재개 | Robert W. Baird | Neutral |
| 2021-02-05 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-11-19 | 개시 | Citigroup | Buy |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-05-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-04-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-03-24 | 업그레이드 | SVB Leerink | Underperform → Mkt Perform |
| 2020-03-17 | 개시 | Goldman | Neutral |
| 2020-01-21 | 개시 | SVB Leerink | Underperform |
| 2019-12-13 | 개시 | Oppenheimer | Perform |
| 2019-11-29 | 재확인 | Chardan Capital Markets | Buy |
| 2019-11-27 | 재확인 | B. Riley FBR | Buy |
| 2019-11-25 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-10-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-10-22 | 재확인 | Chardan Capital Markets | Buy |
| 2019-10-03 | 개시 | Robert W. Baird | Outperform |
| 2018-09-07 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-09-06 | 재확인 | Chardan Capital Markets | Buy |
| 2018-08-08 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-07-02 | 재확인 | Chardan Capital Markets | Buy |
모두보기
Arrowhead Pharmaceuticals Inc 주식(ARWR)의 최신 뉴스
Why Arrowhead Pharmaceuticals Inc. is moving todayQuarterly Profit Summary & Short-Term Trading Alerts - newser.com
Can Arrowhead Pharmaceuticals Inc. stock sustain revenue growth2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com
Arrowhead (NASDAQ: ARWR) to present fazirsiran, zodasiran at AHA/AASLD; Jefferies, TD Cowen - Stock Titan
Will Arrowhead Pharmaceuticals Inc. stock gain from lower inflationQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - newser.com
Advanced analytics toolkit walkthrough for Arrowhead Pharmaceuticals Inc.Weekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com
How sentiment analysis helps forecast Arrowhead Pharmaceuticals Inc.Market Weekly Review & Safe Capital Growth Trade Ideas - newser.com
Trend analysis for Arrowhead Pharmaceuticals Inc. this week2025 Analyst Calls & Momentum Based Trading Signals - newser.com
Will Arrowhead Pharmaceuticals Inc. stock continue dividend increasesWeekly Stock Report & Smart Swing Trading Techniques - newser.com
How to escape a deep drawdown in Arrowhead Pharmaceuticals Inc.Quarterly Earnings Report & Free Fast Entry Momentum Trade Alerts - newser.com
Hypertriglyceridemia: Clinical Landscape, Companies, Therapeutic Assessment, Treatment Algorithm, and Pipeline Insights | Key Players: NorthSea Therapeutics, Arrowhead Pharmaceuticals, Zhejiang Doer B - Barchart.com
Risk vs reward if holding onto Arrowhead Pharmaceuticals Inc.Market Performance Summary & Advanced Technical Analysis Signals - newser.com
Is Arrowhead Pharmaceuticals Inc. stock cheap at current valuationMarket Sentiment Report & Technical Pattern Alert System - newser.com
What dividend safety rating applies to Arrowhead Pharmaceuticals Inc. (HDP1) stockJuly 2025 Macro Moves & High Return Trade Opportunity Guides - newser.com
Will Arrowhead Pharmaceuticals Inc. stock benefit from upcoming earnings reportsMarket Risk Report & Reliable Price Breakout Signals - newser.com
What makes Arrowhead Pharmaceuticals Inc. (HDP1) stock appealing to growth investors2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Will Arrowhead Pharmaceuticals Inc. stock split again soonMarket Risk Analysis & Safe Entry Zone Tips - newser.com
Why Arrowhead Pharmaceuticals Inc. (HDP1) stock signals breakout potential2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com
Pinnacle Associates Ltd. Purchases 70,399 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat
How Arrowhead Pharmaceuticals Inc. (HDP1) stock behaves under inflation pressureEarnings Beat & High Accuracy Swing Entry Alerts - newser.com
How to build a dashboard for Arrowhead Pharmaceuticals Inc. stockJuly 2025 Action & Long-Term Growth Stock Strategies - newser.com
Targeted Drug Delivery Market Set to Witness Massive Growth - openPR.com
Is Arrowhead Pharmaceuticals Inc. showing signs of accumulation2025 Price Momentum & Risk Managed Trade Strategies - newser.com
Why analysts remain bullish on Arrowhead Pharmaceuticals Inc. stockWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
Can Arrowhead Pharmaceuticals Inc. stock hit analyst price targets2025 Pullback Review & Expert Curated Trade Ideas - newser.com
Is Arrowhead Pharmaceuticals Inc. stock attractive for growth ETFsJuly 2025 Breakouts & High Yield Equity Trading Tips - newser.com
Best data tools to analyze Arrowhead Pharmaceuticals Inc. stockQuarterly Performance Summary & Accurate Trade Setup Notifications - newser.com
Can Arrowhead Pharmaceuticals Inc. stock reach $100 price targetEarnings Overview Report & Daily Technical Stock Forecast Reports - newser.com
Arrowhead Pharmaceuticals Inc (ARWR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):